Published in Clin Pharmacol Ther on May 01, 1987
Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis (2002) 1.75
Early ribavirin pharmacokinetics, HCV RNA and alanine aminotransferase kinetics in HIV/HCV co-infected patients during treatment with pegylated interferon and ribavirin. J Hepatol (2007) 1.74
Ribavirin and interferon alfa-2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions. Br J Clin Pharmacol (1998) 1.72
Effects of drugs on 2',3'-dideoxy-2',3'-didehydrothymidine phosphorylation in vitro. Antimicrob Agents Chemother (1997) 1.66
Pharmacokinetics and absolute bioavailability of ribavirin in healthy volunteers as determined by stable-isotope methodology. Antimicrob Agents Chemother (1999) 1.21
High-performance liquid chromatographic determination of ribavirin in whole blood to assess disposition in erythrocytes. Antimicrob Agents Chemother (1999) 1.10
Safety, tolerance, and pharmacokinetics of systemic ribavirin in children with human immunodeficiency virus infection. Antimicrob Agents Chemother (1993) 1.07
High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassay. Antimicrob Agents Chemother (1989) 1.04
Pharmacokinetics and metabolism of [14C]viramidine in rats and cynomolgus monkeys. Antimicrob Agents Chemother (2003) 0.98
Drug interactions with zidovudine phosphorylation in vitro. Antimicrob Agents Chemother (1995) 0.94
Pharmacokinetics and metabolism of [(14)C]ribavirin in rats and cynomolgus monkeys. Antimicrob Agents Chemother (2003) 0.94
Population pharmacokinetic modeling of plasma and intracellular ribavirin concentrations in patients with chronic hepatitis C virus infection. Antimicrob Agents Chemother (2015) 0.93
Disposition and metabolic profiles of [14C]viramidine and [14C]ribavirin in rat and monkey red blood cells and liver. Antimicrob Agents Chemother (2004) 0.87
Pharmacokinetics of ribavirin in combined interferon-alpha 2b and ribavirin therapy for chronic hepatitis C virus infection. Br J Clin Pharmacol (2003) 0.86
High-dose intravenous ribavirin therapy for subacute sclerosing panencephalitis. Antimicrob Agents Chemother (2001) 0.86
The role of nucleoside transporters in the erythrocyte disposition and oral absorption of ribavirin in the wild-type and equilibrative nucleoside transporter 1-/- mice. J Pharmacol Exp Ther (2009) 0.84
Failure of interferon alfa and tribavirin in rabies encephalitis. BMJ (1989) 0.83
The single dose pharmacokinetics of ribavirin in subjects with chronic liver disease. Br J Clin Pharmacol (2000) 0.82
Management of hepatitis C in patients with chronic kidney disease. World J Gastroenterol (2015) 0.78
Hemodialysis clearance of intravenously administered ribavirin. Antimicrob Agents Chemother (1990) 0.78
Absorption, metabolism, and excretion of [14C]viramidine in humans. Antimicrob Agents Chemother (2006) 0.77
The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 13.84
High-Resolution Density Gradient Sedimentation Analysis. Science (1960) 12.12
SYNTHESIS OF NASCENT PROTEIN BY RIBOSOMES IN ESCHERICHIA COLI. Proc Natl Acad Sci U S A (1959) 8.76
The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial. N Engl J Med (1987) 8.52
The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus aureus infection. N Engl J Med (1999) 7.64
AMINO ACID ADSORPTION AND PROTEIN SYNTHESIS IN Escherichia Coli. Proc Natl Acad Sci U S A (1955) 6.29
Campylobacteriosis in man: pathogenic mechanisms and review of 91 bloodstream infections. Am J Med (1978) 4.56
Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics. Pediatr Infect Dis J (1991) 4.08
Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficiency syndrome. N Engl J Med (1984) 3.73
Viridans streptococcal endocarditis: the role of various species, including pyridoxal-dependent streptococci. Rev Infect Dis (1980) 3.70
Acyclovir prophylaxis of herpes-simplex-virus infections. N Engl J Med (1981) 3.19
The Synthesis of Ribosomes in E. coli: III. Synthesis of Ribosomal RNA. Biophys J (1962) 3.14
The protean manifestations of Mycoplasma pneumoniae infection in adults. Am J Med (1975) 3.06
Hemizygous expression of glucose-6-phosphate dehydrogenase in erythrocytes of heterozygotes for the Lesch-Nyhan syndrome. Proc Natl Acad Sci U S A (1970) 3.05
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98
The relationship between group A and group C meningococcal polysaccharides and serum opsonins in man. J Exp Med (1970) 2.97
The interaction in vitro between group B meningococci and rabbit polymorphonuclear leukocytes. Demonstration of type specific opsonins and bactericidins. J Exp Med (1967) 2.89
A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med (1984) 2.71
Streptococcus bovis bacteremia and underlying gastrointestinal disease. Arch Intern Med (1978) 2.54
Double-blind comparison of the nephrotoxicity and auditory toxicity of gentamicin and tobramycin. N Engl J Med (1980) 2.51
Serious infections caused by Streptococcus milleri. Am J Med (1978) 2.47
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Vitamin B6-dependent Streptococcus mitior (mitis) isolated from patients with systemic infections. J Infect Dis (1975) 2.37
Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis (1994) 2.30
Isolation and characterisation of resistant Herpes simplex virus after acyclovir therapy. Lancet (1982) 2.28
Treatment of recurrent genital herpes simplex infections with oral acyclovir. A controlled trial. JAMA (1984) 2.20
Homophobia among physicians and nurses: an empirical study. Hosp Community Psychiatry (1985) 2.10
A pneumococcal clinical isolate with high-level resistance to cefotaxime and ceftriaxone. Antimicrob Agents Chemother (1992) 2.07
Methotrexate pharmacokinetics. J Pharm Sci (1971) 1.94
Acyclovir halts progression of herpes zoster in immunocompromised patients. N Engl J Med (1983) 1.90
Therapy of herpes zoster with oral acyclovir. Am J Med (1988) 1.89
Patients at risk for AIDS-related opportunistic infections. Clinical manifestations and impaired gamma interferon production. N Engl J Med (1985) 1.87
Prolonged zidovudine therapy in patients with AIDS and advanced AIDS-related complex. AZT Collaborative Working Group. JAMA (1989) 1.84
Diagnosis of enteroviral central nervous system infection by polymerase chain reaction during a large community outbreak. Pediatr Infect Dis J (1994) 1.83
Memory in mice analyzed with antibiotics. Antibiotics are useful to study stages of memory and to indicate molecular events which sustain memory. Science (1967) 1.81
Mycobacterium avium-M. intracellulare isolates from patients with or without acquired immunodeficiency syndrome. Antimicrob Agents Chemother (1986) 1.79
Cryptosporidiosis in homosexual men. Ann Intern Med (1984) 1.79
Antimicrobial therapy of vitamin B6-dependent streptococcal endocarditis. Ann Intern Med (1977) 1.77
The metabolism of ribavirin in erythrocytes and nucleated cells. Int J Biochem (1990) 1.77
Antimicrobial therapy of experimental enterococcal endocarditis. Antimicrob Agents Chemother (1975) 1.75
Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections. Antimicrob Agents Chemother (1987) 1.74
Salmonella infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.69
The L form of Neisseria meningitidis. J Gen Microbiol (1966) 1.69
Pasteurella multocida infection; report in urban setting and review of spectrum of human disease. N Y State J Med (1980) 1.62
Intravenous acyclovir for the treatment of primary genital herpes. Ann Intern Med (1983) 1.59
Reducing the risk of acid aspiration during cesarean section. Anesth Analg (1975) 1.58
Gentamicin levels in the human biliary tract. J Infect Dis (1973) 1.58
Interrelationships of viral, mycoplasmal, and bacterial agents in uncomplicated pneumonia. Am Rev Respir Dis (1968) 1.58
Studies of the continuing susceptibility of group A streptococcal strains to penicillin during eight decades. Pediatr Infect Dis J (1998) 1.54
T4+ cell production of interferon gamma and the clinical spectrum of patients at risk for and with acquired immunodeficiency syndrome. Arch Intern Med (1988) 1.53
In vitro and in vivo activation of human mononuclear phagocytes by interferon-gamma. Studies with normal and AIDS monocytes. J Immunol (1987) 1.51
Herpes zoster and zosteriform herpes simplex virus infections in immunocompetent adults. Am J Med (1986) 1.50
The interaction in vitro between human polymorphonuclear leukocytes and Neisseria gonorrhoeae cultivated in the chick embryo. J Exp Med (1975) 1.50
Risk factors associated with vancomycin-resistant Enterococcus faecium infection or colonization in 145 matched case patients and control patients. Clin Infect Dis (1996) 1.48
Attachment of virulent Treponema pallidum to human mononuclear phagocytes. Br J Vener Dis (1978) 1.48
The risk of exposure of third-year surgical clerks to human immunodeficiency virus in the operating room. Arch Surg (1993) 1.46
Plague in San Diego. West J Med (1978) 1.45
Double-blind controlled trial of topical acyclovir in genital herpes simplex virus infections. Am J Med (1982) 1.42
Treatment of cytomegalovirus pneumonia with high-dose acyclovir. Am J Med (1982) 1.41
Loss of memory as related to inhibition of cerebral protein synthesis. J Neurochem (1965) 1.41
Use of ganciclovir to treat serious cytomegalovirus infections in patients with AIDS. J Infect Dis (1987) 1.37
Generalized type 5 adenovirus infection associated with the pertussis syndrome. J Pediatr (1966) 1.37
Sensitive radioimmunoassay for the broad-spectrum antiviral agent ribavirin. Antimicrob Agents Chemother (1983) 1.35
Synthesis of the Aspartic and Glutamic Families of Amino Acids in Escherichia Coli. Proc Natl Acad Sci U S A (1953) 1.34
The antiviral effect of zidovudine and ribavirin in clinical trials and the use of p24 antigen levels as a virologic marker. J Infect Dis (1989) 1.32
Recovery of adrenal reserve following treatment of disseminated South American blastomycosis. Am J Med (1981) 1.31
Evidence for an etiologic role of adenoviral infection in pertussis syndrome. N Engl J Med (1970) 1.30
Effect of adenosine deaminase upon the antiviral activity in vitro of adenine arabinoside for vaccinia virus. Antimicrob Agents Chemother (1974) 1.30
Acyclovir and suppression of frequently recurring herpetic whitlow. Ann Intern Med (1985) 1.29
Determination of plaque inhibitory activity of adenine arabinoside (9-beta-D-arabinofuranosyladenine) for herpesviruses using an adenosine deaminase inhibitor. Antimicrob Agents Chemother (1974) 1.28
Disposition of intravenous radioactive acyclovir. Clin Pharmacol Ther (1981) 1.27
Adenovirus type 7b in a children's hospital. J Infect Dis (1983) 1.26
Extraintestinal manifestations of shigellosis. Am J Gastroenterol (1970) 1.25
In vitro susceptibility of varicella zoster virus to adenine arabinoside and hypoxanthine arabinoside. Antimicrob Agents Chemother (1976) 1.24
Single-dose pharmacokinetics of acyclovir. Antimicrob Agents Chemother (1981) 1.23
Ganciclovir for the treatment and suppression of serious infections caused by cytomegalovirus. Am J Med (1987) 1.22
Effect of oral acyclovir on pain resolution in herpes zoster: a reanalysis. J Med Virol (1993) 1.22
Pharmacokinetics of transdermal testosterone gel in hypogonadal men: application of gel at one site versus four sites: a General Clinical Research Center Study. J Clin Endocrinol Metab (2000) 1.21
The influences of renal function and maturation on vancomycin elimination in newborns and infants. J Clin Pharmacol (2001) 1.21
Interbacterial transfer of R factor in the human intestine: in-vivo acquisition of R-factor-mediated kanamycin resistance by a multiresistant strain of Shigella sonnei. J Infect Dis (1972) 1.21
The biochemical basis of long-term memory. Q Rev Biophys (1969) 1.21
Practical approach to the identification of clinically relevant Enterococcus species. Diagn Microbiol Infect Dis (1999) 1.20
Enzyme-linked immunosorbent assay for the detection of antibodies to nutritionally variant streptococci in patients with endocarditis. J Infect Dis (1986) 1.20
Weekly oral azithromycin as prophylaxis for agents causing acute respiratory disease. Clin Infect Dis (1998) 1.19
Prospective randomized study of therapy in cerebrospinal fluid shunt infection. Neurosurgery (1980) 1.19
Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. Pediatr Infect Dis J (2001) 1.18
Specificity of a rat behavioral model for serotonin receptor activation. J Pharmacol Exp Ther (1978) 1.16
Clinical pharmacokinetics of acyclovir. Clin Pharmacokinet (1983) 1.16
Why have group A streptococci remained susceptible to penicillin? Report on a symposium. Clin Infect Dis (1998) 1.16
Neonatal herpes simplex virus infection: follow-up evaluation of vidarabine therapy. Pediatrics (1983) 1.16
Production of and in vitro response to interleukin 2 in the acquired immunodeficiency syndrome. J Clin Invest (1985) 1.15
L form of Neisseria gonorrhoeae. J Bacteriol (1966) 1.14